Convalescent Plasma in Pediatric COVID-19

Summary

COVID-19 is increasingly affecting children but convalescent plasma (CP) has not been adequately studied in children to date. The study will determine safety of convalescent plasma for pediatric patients with severe, or at high risk for severe, COVID-19 disease.

Timeline

Start

2020-07-04

Primary completion

2020-09-01

Completion

2020-09-01

Drugs

Indications